世界の子宮内避妊器具(IUD)市場2020-2024

◆英語タイトル:Global Intrauterine Contraceptive Devices (IUD) Market 2020-2024
◆商品コード:IRTNTR44874
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年8月26日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:ヨーロッパ、北米、アジア、その他の国
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、子宮内避妊器具(IUD)の世界市場を調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、エンドユーザー別(病院、婦人科クリニック、その他)分析、種類別(ホルモン性子宮内避妊器具、銅付加子宮内避妊具)分析、顧客状況、地域別状況、企業状況、企業分析などの項目を掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・子宮内避妊器具(IUD)の世界市場規模:エンドユーザー別(病院、婦人科クリニック、その他)
・子宮内避妊器具(IUD)の世界市場規模:種類別(ホルモン性子宮内避妊器具、銅付加子宮内避妊具)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Intrauterine Contraceptive Devices (IUD) Market 2020-2024
Technavio has been monitoring the intrauterine contraceptive devices (IUD) market and it is poised to grow by $ 597.40 mn during 2020-2024 progressing at a CAGR of 3% during the forecast period. Our reports on intrauterine contraceptive devices (IUD) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the initiatives taken by governments and non-profit organizations and the effectiveness of IUDs. In addition, initiatives taken by governments and non-profit organizations is anticipated to boost the growth of the market as well.

The intrauterine contraceptive devices (IUD) market analysis includes end-user segment and geographical landscapes.
Technavio’s intrauterine contraceptive devices (IUD) market is segmented as below:

By End-user
• Hospitals
• Gynecology clinics
• Others

By Type
• Hormonal intrauterine device
• Copper intrauterine device

By Geographical landscapes
• Europe
• North America
• Asia
• ROW

This study identifies the increasing rate of unintended pregnancies and unwanted abortions as one of the prime reasons driving the intrauterine contraceptive devices (IUD) market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our intrauterine contraceptive devices (IUD) market covers the following areas:
• Intrauterine contraceptive devices (IUD) market sizing
• Intrauterine contraceptive devices (IUD) market forecast
• Intrauterine contraceptive devices (IUD) market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading intrauterine contraceptive devices (IUD) market vendors that include AbbVie Inc., Bayer AG, DKT International, EUROGINE SL, Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Mylan NV, Pregna International Ltd., Prosan International BV, and The Cooper Companies Inc. Also, the intrauterine contraceptive devices (IUD) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/intrauterine-contraceptive-devices-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by End-user
o Market segments
o Comparison by End-user
o Hospitals – Market size and forecast 2019-2024
o Gynecology clinics – Market size and forecast 2019-2024
o Others – Market size and forecast 2019-2024
o Market opportunity by End-user
• Market Segmentation by Type
o Market segments
o Comparison by Type
o Hormonal intrauterine device – Market size and forecast 2019-2024
o Copper intrauterine device – Market size and forecast 2019-2024
o Market opportunity by Type
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o Europe – Market size and forecast 2019-2024
o North America – Market size and forecast 2019-2024
o Asia – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o AbbVie Inc.
o Bayer AG
o DKT International
o EUROGINE SL
o Laboratoire HRA Pharma SAS
o Melbea Innovations Ltd.
o Mylan NV
o Pregna International Ltd.
o Prosan International BV
o The Cooper Companies Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Parent market
• 10: Market characteristics
• 11: Offerings of vendors included in the market definition
• 12: Market segments
• 13: Global – Market size and forecast 2019 – 2024 ($ million)
• 14: Global market: Year-over-year growth 2019 – 2024 (%)
• 15: Five forces analysis 2019 & 2024
• 16: Bargaining power of buyers
• 17: Bargaining power of suppliers
• 18: Threat of new entrants
• 19: Threat of substitutes
• 20: Threat of rivalry
• 21: Market condition – Five forces 2019
• 22: End user – Market share 2019-2024 (%)
• 23: Comparison by End user
• 24: Hospitals – Market size and forecast 2019-2024 ($ million)
• 25: Hospitals – Year-over-year growth 2019-2024 (%)
• 26: Gynecology clinics – Market size and forecast 2019-2024 ($ million)
• 27: Gynecology clinics – Year-over-year growth 2019-2024 (%)
• 28: Others – Market size and forecast 2019-2024 ($ million)
• 29: Others – Year-over-year growth 2019-2024 (%)
• 30: Market opportunity by End user
• 31: Type – Market share 2019-2024 (%)
• 32: Comparison by Type
• 33: Hormonal intrauterine device – Market size and forecast 2019-2024 ($ million)
• 34: Hormonal intrauterine device – Year-over-year growth 2019-2024 (%)
• 35: Copper intrauterine device – Market size and forecast 2019-2024 ($ million)
• 36: Copper intrauterine device – Year-over-year growth 2019-2024 (%)
• 37: Market opportunity by Type
• 38: Customer landscape
• 39: Market share by geography 2019-2024 (%)
• 40: Geographic comparison
• 41: Europe – Market size and forecast 2019-2024 ($ million)
• 42: Europe – Year-over-year growth 2019-2024 (%)
• 43: North America – Market size and forecast 2019-2024 ($ million)
• 44: North America – Year-over-year growth 2019-2024 (%)
• 45: Asia – Market size and forecast 2019-2024 ($ million)
• 46: Asia – Year-over-year growth 2019-2024 (%)
• 47: ROW – Market size and forecast 2019-2024 ($ million)
• 48: ROW – Year-over-year growth 2019-2024 (%)
• 49: Key leading countries
• 50: Market opportunity by geography ($ million)
• 51: Impact of drivers and challenges
• 52: Vendor landscape
• 53: Landscape disruption
• 54: Industry risks
• 55: Vendors covered
• 56: Market positioning of vendors
• 57: AbbVie Inc. – Overview
• 58: AbbVie Inc. – Business segments
• 59: AbbVie Inc. – Key offerings
• 60: AbbVie Inc. – Key customers
• 61: AbbVie Inc. – Segment focus
• 62: Bayer AG – Overview
• 63: Bayer AG – Business segments
• 64: Bayer AG – Key offerings
• 65: Bayer AG – Key customers
• 66: Bayer AG – Segment focus
• 67: DKT International – Overview
• 68: DKT International – Product and service
• 69: DKT International – Key offerings
• 70: DKT International – Key customers
• 71: DKT International – Segment focus
• 72: EUROGINE SL – Overview
• 73: EUROGINE SL – Product and service
• 74: EUROGINE SL – Key offerings
• 75: EUROGINE SL – Key customers
• 76: EUROGINE SL – Segment focus
• 77: Laboratoire HRA Pharma SAS – Overview
• 78: Laboratoire HRA Pharma SAS – Product and service
• 79: Laboratoire HRA Pharma SAS – Key offerings
• 80: Laboratoire HRA Pharma SAS – Key customers
• 81: Laboratoire HRA Pharma SAS – Segment focus
• 82: Melbea Innovations Ltd. – Overview
• 83: Melbea Innovations Ltd. – Product and service
• 84: Melbea Innovations Ltd. – Key offerings
• 85: Melbea Innovations Ltd. – Key customers
• 86: Melbea Innovations Ltd. – Segment focus
• 87: Mylan NV – Overview
• 88: Mylan NV – Business segments
• 89: Mylan NV – Key offerings
• 90: Mylan NV – Key customers
• 91: Mylan NV – Segment focus
• 92: Pregna International Ltd. – Overview
• 93: Pregna International Ltd. – Product and service
• 94: Pregna International Ltd. – Key offerings
• 95: Pregna International Ltd. – Key customers
• 96: Pregna International Ltd. – Segment focus
• 97: Prosan International BV – Overview
• 98: Prosan International BV – Product and service
• 99: Prosan International BV – Key offerings
• 100: Prosan International BV – Key customers
• 101: Prosan International BV – Segment focus
• 102: The Cooper Companies Inc. – Overview
• 103: The Cooper Companies Inc. – Business segments
• 104: The Cooper Companies Inc. – Key offerings
• 105: The Cooper Companies Inc. – Key customers
• 106: The Cooper Companies Inc. – Segment focus
• 107: Currency conversion rates for US$
• 108: Research Methodology
• 109: Validation techniques employed for market sizing
• 110: Information sources
• 111: List of abbreviations



【掲載企業】

AbbVie Inc., Bayer AG, DKT International, EUROGINE SL, Laboratoire HRA Pharma SAS, Melbea Innovations Ltd., Mylan NV, Pregna International Ltd., Prosan International BV, The Cooper Companies Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の子宮内避妊器具(IUD)市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆